轻链和重链沉积病的临床病理特征:病例系列
该病例系列描述了13例活检证实的轻链和重链沉积病(LHCDD)患者的临床病理特征及结局。患者多表现为高血压、贫血、血肌酐升高和蛋白尿,最常见沉积为单克隆IgG1-κ,超过半数可评估患者有血液学反应但肾脏反应少见。
要点
- LHCDD常表现为高血压、贫血、血肌酐升高和蛋白尿
- 最常见沉积为单克隆IgG1-κ,结节性系膜硬化常见
- 血液学反应较常见,但肾脏反应不常见
核心结论
- LHCDD肾脏组织沉积最常见为单克隆IgG1-κ,可评估患者中超过半数有血液学反应但肾脏反应不常见。
研究设计与样本
- 病例系列,纳入2008年1月至2022年12月中国2家医疗中心活检证实的13例LHCDD患者。
主要发现
- 13例患者中男6例女7例,平均年龄52.6±8.0岁。
- 临床表现为高血压76.9%、贫血84.6%、血肌酐升高84.6%(中位数1.7mg/dL)、蛋白尿100%(平均尿蛋白3.0g/24h)、肾病综合征30.8%、镜下血尿76.9%。
- 血清免疫固定电泳显示单克隆Ig者11例(84.6%),血清游离轻链比值异常11例(84.6%),重链/轻链比值异常9/10例(90%)。
- 5例诊断为多发性骨髓瘤,10例(76.9%)组织学诊断为结节性系膜硬化。
- 免疫荧光显示IgG亚类沉积7例(γ-κ 4例,γ-λ 3例),IgA沉积5例(α-κ 2例,α-λ 3例);6例进行IgG亚类染色(γ1 3例,γ2 2例,γ3 1例);1例经质谱证实IgD-κ沉积。
关键数值与推荐
- 中位随访26.5个月,12例有数据患者中11例接受化疗、1例保守治疗;1例死亡,3例(25%)进展至肾衰竭。
- 9例可评估血液学和肾脏病进展的患者中,5例(56%)有血液学反应,1例(11%)肾脏病改善。
临床怎么用
- 对疑似单克隆免疫球蛋白沉积病患者应完善血清免疫固定电泳、游离轻链比值及重链/轻链比值检测。
- 肾活检免疫荧光应包含IgG亚类及IgA染色以明确沉积类型。
局限性
- 回顾性描述性研究,患者数量有限。
- 多数患者缺少尿蛋白电泳或免疫固定电泳检测结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Light and heavy chain deposition disease (LHCDD) is a rare form of monoclonal immunoglobulin (Ig) deposition disease, and limited clinical data are available characterizing this condition. Here we describe the clinicopathological characteristics and outcomes of LHCDD. STUDY DESIGN: Case series. SETTING & PARTICIPANTS: 13 patients with biopsy-proven LHCDD diagnosed between January 2008 and December 2022 at one of 2 Chinese medical centers. FINDINGS: Among the 13 patients described, 6 were men and 7 were women, with a mean age of 52.6±8.0 years. Patients presented with hypertension (76.9%), anemia (84.6%), increased serum creatinine concentrations (84.6%; median, 1.7mg/dL), proteinuria (100%; average urine protein, 3.0g/24h), nephrotic syndrome (30.8%), and microscopic hematuria (76.9%). Serum immunofixation electrophoresis showed monoclonal Ig for 11 patients (84.6%). Serum free light chain ratios were abnormal in 11 patients (84.6%), and heavy/light chain ratios were abnormal in 9 of 10 patients (90%) with available data. Five patients were diagnosed with multiple myeloma. A histological diagnosis of nodular mesangial sclerosis was made in 10 patients (76.9%). Immunofluorescence demonstrated deposits of IgG subclass in 7 patients (γ-κ, n=4; γ-λ, n=3) and IgA in 5 patients (α-κ, n=2; α-λ, n=3). Six patients underwent IgG subclass staining (γ1, n=3; γ2, n=2; γ3, n=1). The deposits of IgD-κ were confirmed by mass spectrometry in 1 patient. Among 12 patients for whom data were available during a median of 26.5 months, 11 received chemotherapy and 1 received conservative treatment. One patient died, and disease progressed to kidney failure in 3 (25%). Among the 9 patients evaluable for hematological and kidney disease progression, 5 (56%) had a hematologic response and 1 (11%) exhibited improvement in kidney disease. LIMITATIONS: Retrospective descriptive study, limited number of patients, urine protein electrophoresis or immunofixation electrophoresis test results missing for most patients. CONCLUSIONS: In this case series of LHCDD, light and heavy chain deposition in kidney tissues were most frequent with monoclonal IgG1-κ. Among patients with evaluable data, more than half had a hematologic response, but a kidney response was uncommon.
引用
- Wang Y, Chen D, Hu R, et al. Clinicopathological Characteristics of Light and Heavy Chain Deposition Disease: A Case Series. Am J Kidney Dis. 2024. PMID: 38750878. doi:10.1053/j.ajkd.2024.03.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。